LPTI Longport Inc (CE)

Longport, Inc., (OTC BB: LPTI), a medical technology specialist in high resolution ultrasound imaging, announced today that it has received a purchase order for two EPISCAN I-200 ultrasound scanners and has additionally entered into three separate rental agreements. Maximum Medical, Inc. has ordered scanners to be placed at two facilities that primarily serve a Native American population. These facilities will be using the scanners in wound care and prevention applications. At the same time, Longport has placed three units in the UK under a rental agreement with an international aesthetic company to assess the impact of an anti-aging process. Longport has also rented another unit to a major manufacturer of medical lasers in the U.S. to assess the impact of a laser-based aesthetic procedure. Finally, an internationally recognized hospital in Switzerland is renting an EPISCAN I-200 for use in a dermatology study. Paul Wilson, President of Longport, said, "We are very pleased to have signed these agreements, which show sales originating from a distributor as well as Longport's direct efforts. I congratulate Maximum Medical on their success. These agreements also demonstrate that our technology has applications in several diverse markets. Moreover, the placement of units in both Europe and the U.S. illustrates our international reach. We expect to announce further sales and rentals in the near future." Tony Oglesby, President of Maximum Medical, said, "I am encouraged by the reception and interest level at the facilities where our sales team has introduced the EPISCAN I-200. We look forward to increasing sales numbers, as practitioners see the ease and efficacy of the technology." About Longport, Inc. Longport, Inc. of Glen Mills, Pennsylvania, is a medical technology company that specializes in high resolution ultrasound imaging. After several years and a multi-million dollar investment in the technology, Longport has secured patents, copyrights, and FDA permission to market. The Company's technology has been used to engineer a unique high resolution ultrasound imaging system. For further information please contact Longport, Inc. at 1-800-289-6863 or visit our website at www.longportinc.com. Forward-looking Information and the Private Securities Litigation Reform Act of 1995 Certain statements in this press release, including statements concerning product development milestones and anticipated events, are "forward-looking statements" within the Private Litigation Reform Act of 1995. Forward Looking Statements are based on the opinions and estimates of management at the time the statements are made and are subject to certain risks and uncertainties that could cause actual results to differ materially from those anticipated in the forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could affect Longport's actual results include, among others, uncertainties as to the Company's ability to manage potential problems, delays or anticipated expenses, including problems, delays or expenses involving manufacturing. Readers are cautioned not to place undue reliance upon these forward-looking statements that speak only to the date of this release. Reference is made to Longport's 2004 annual report on Form 10-K filed with the Securities and Exchange Commission for a more definitive description of such factors. Longport, Inc. undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date of this release or to reflect the occurrence of unanticipated events.